Lalco Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 1.40 M
- Company Age 24 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.32 Cr
- Revenue Growth 15.78%
- Profit Growth 20.85%
- Ebitda 14.07%
- Net Worth 15.56%
- Total Assets -1.20%
About Lalco Pharma
Lalco Pharma Private Limited (LPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 13 March 2000 and has a history of 24 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.40 M.
The company currently has active open charges totaling ₹1.32 Cr.
Abhay Agarwal, Ajay Aggarwal, Atul Agarwal, and One other member serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24239DL2000PTC104377
-
Company No.
104377
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Mar 2000
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Lalco Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Abhay Agarwal
|
Managing Director | 13-Mar-2000 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Ajay Aggarwal
|
Director | 13-Mar-2000 | Current |
|
Atul Agarwal
|
Director | 13-Mar-2000 | Current |
|
Anup Aggarwal
|
Director | 13-Mar-2000 | Current |
Financial Performance of Lalco Pharma.
Lalco Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 15.78% increase. The company also saw a substantial improvement in profitability, with a 20.85% increase in profit. The company's net worth Soared by an impressive increase of 15.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lalco Pharma?
In 2022, Lalco Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Truely Rx Healthcare Private LimitedAbhay Agarwal is a mutual person
Charges (Loans)
₹13.20 M
₹0
Charges Breakdown by Lending Institutions
- Union Bank Of India : 1.08 Cr
- Others : 0.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jun 2020 | Others | ₹1.50 M | Open |
| 29 May 2020 | Others | ₹0.90 M | Open |
| 12 Oct 2001 | Union Bank Of India | ₹1.80 M | Open |
| 18 Dec 2000 | Union Bank Of India | ₹9.00 M | Open |
How Many Employees Work at Lalco Pharma?
Unlock and access historical data on people associated with Lalco Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lalco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lalco Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
